Biomarker Target - Mechanism of Action + Real World Data

Citeline Clinical provides comprehensive real-time R&D intelligence to the life sciences industry, featuring an unmatched collection of global clinical trials data, vetted investigators, trial sites and drug development pipelines. Our content is curated by the industry’s largest team of expert analysts, making Citeline Clinical an unparalleled source of R&D intelligence.

The Biomarker Target or Mechanism of Action + Real World Data (RWD) data package provides a comprehensive dataset to evaluate and analyze the competitive landscape of a clinical trial, and trial details, within a particular biomarker target or mechanism of action. It pulls together the most relevant data points from the Pharmaprojects, Trialtrove, and Sitetrove data sources, and surfaces insights into various aspects of drug evaluation, clinical trials, and benchmarks from over the past five years. Additionally, the packages includes patient claims and diversity data from over the past two years.

Pharmaprojects

• 100,000+ total drug profiles
• 6,000+ drug profiles added per year
• 58,000+ data sources
• 19,600+ drugs in active development
• 3,700+ mechanisms
• 3,100+ targets
• 1,700+ diseases
• 600+ rare diseases

Trialtrove
Over half of all trials found in Trialtrove cannot be found in ClinicalTrials.gov; data is constantly curated from over 58,000 unique sources and the number of sources per TA has increased by ~40% since 2015

The clinical trial record is further populated by our Analyst team using supplementary sources and enriched with custom tagging to classify and categorize patient segments, trial tags/attributes, outcomes and more.

• 430,000+ trials (phases I-IV)
• 58,000+ data sources
• 3,400+ patient segments
• 1,350+ endpoints
• 310+ diseases across 9 therapeutic areas
• 200+ countries in all geographic areas

Sitetrove features 550,000+ investigators from 194,000+ sites across 185+ countries to accelerate trial planning and execution.

Citeline Real World Data assets feature 300M+ patients , 32B+ Claims, 2.1M+ HCPs, and 98% of Payers.

The following sets of data have been included in this listing:
Trials – By Biomarker Target
Biomarkers -By Synonyms
Biomarkers – By Utility
Trials - By Therapeutic Area, Disease, Patient Segment
Trials - Details by Phase, Status, and Benchmarks for Sites/Patients
Trials - By Country/Region
Trials - By Drug
Trials - By Sponsors
Trials - By Tags/Attributes
Trials - By Outcomes
Trials - By Study Design Attributes
Trials - by Primary Endpoints
Trials - Benchmarks by Patients per Site per Month per Sponsor
Trials - Benchmarks by Patients per Site per Month per Disease
Trials - Benchmark Sites per Country
Drugs - By Company, Status
Drugs - By Mechanism of Action
Drugs - By Biological Target
Drugs - By Therapeutic Class
Disease - By ICD10 Codes
Investigator – Investigator Contact Details
Investigator – By Trial
Investigator – By Site
Investigator – By Affiliated Site
Investigator – By Sponsor
Investigator – By Specialty
Investigator – By Network
Investigator – By Tier
Site - Site Location Details
Site - By Trial
Site - By NPI
Site - By Sponsor Relationship
Site - By Hierarchy

Includes additional data from the Real World Data asset:

Investigator - Patient Landscape
Site - Patient Landscape
Investigator - Patient Diversity
Site - Patient Diversity
HCP - Profiles
HCP - Patient Diversity

You can use this data to analyze trends, make predictions, and inform your decision-making process in the pharmaceutical industry.

Once you subscribe to this listing, you will have access to all the data tables required.
Workflow:
• Consumer clicks “Request” on Citeline listing;
• Citeline will reach out to the consumer and finalize terms;
• Citeline shares the data package with the consumer via Snowflake shares.

Additional Information:
This data package is updated regularly to ensure that you have the most recent and accurate information. If you have any questions or need further information, please don’t hesitate to contact us.

搜集汇总

背景与挑战

背景概述

该数据集整合了Pharmaprojects、Trialtrove和Sitetrove等多个来源的临床试验与真实世界数据，聚焦生物标志物靶点或作用机制，用于评估竞争格局和试验详情。它包含药物档案、试验记录、研究者信息及患者多样性数据，支持制药行业的趋势分析和决策制定。